These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 20443884)
1. Preclinical safety validation of a stabilized viral vector direct injection approach to the cervical spinal cord. Federici T; Riley J; Park J; Bain M; Boulis N Clin Transl Sci; 2009 Apr; 2(2):165-7. PubMed ID: 20443884 [TBL] [Abstract][Full Text] [Related]
2. Cervical spinal cord therapeutics delivery: preclinical safety validation of a stabilized microinjection platform. Riley J; Federici T; Park J; Suzuki M; Franz CK; Tork C; McHugh J; Teng Q; Svendsen C; Boulis NM Neurosurgery; 2009 Oct; 65(4):754-61; discussion 761-2. PubMed ID: 19834381 [TBL] [Abstract][Full Text] [Related]
3. AAV-Mediated Gene Delivery to the Spinal Cord by Intrathecal Injection. Peterson CD; Skorput AGJ; Kitto KF; Wilcox GL; Vulchanova L; Fairbanks CA Methods Mol Biol; 2019; 1950():199-207. PubMed ID: 30783975 [TBL] [Abstract][Full Text] [Related]
4. Focused ultrasound as a novel strategy for noninvasive gene delivery to retinal Müller glia. Touahri Y; Dixit R; Kofoed RH; Miloska K; Park E; Raeisossadati R; Markham-Coultes K; David LA; Rijal H; Zhao J; Lynch M; Hynynen K; Aubert I; Schuurmans C Theranostics; 2020; 10(7):2982-2999. PubMed ID: 32194850 [TBL] [Abstract][Full Text] [Related]
6. Global diffuse distribution in the brain and efficient gene delivery to the dorsal root ganglia by intrathecal injection of adeno-associated viral vector serotype 1. Iwamoto N; Watanabe A; Yamamoto M; Miyake N; Kurai T; Teramoto A; Shimada T J Gene Med; 2009 Jun; 11(6):498-505. PubMed ID: 19338016 [TBL] [Abstract][Full Text] [Related]
8. Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins. Klein RL; Dayton RD; Leidenheimer NJ; Jansen K; Golde TE; Zweig RM Mol Ther; 2006 Mar; 13(3):517-27. PubMed ID: 16325474 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Photoreceptor Transduction Efficacy of Capsid-Modified Adeno-Associated Viral Vectors Following Intravitreal and Subretinal Delivery in Sheep. Ross M; Obolensky A; Averbukh E; Ezra-Elia R; Yamin E; Honig H; Dvir H; Rosov A; Hauswirth WW; Gootwine E; Banin E; Ofri R Hum Gene Ther; 2020 Jul; 31(13-14):719-729. PubMed ID: 32486858 [TBL] [Abstract][Full Text] [Related]
10. Cervical spinal cord delivery of a rabies G protein pseudotyped lentiviral vector in the SOD-1 transgenic mouse. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. Tanase K; Teng Q; Krishnaney AA; Liu JK; Garrity-Moses ME; Boulis NM J Neurosurg Spine; 2004 Jul; 1(1):128-36. PubMed ID: 15291033 [TBL] [Abstract][Full Text] [Related]
11. Targeted retrograde gene delivery into the injured cervical spinal cord using recombinant adenovirus vector. Nakajima H; Uchida K; Kobayashi S; Kokubo Y; Yayama T; Sato R; Baba H Neurosci Lett; 2005 Sep; 385(1):30-5. PubMed ID: 15936879 [TBL] [Abstract][Full Text] [Related]
12. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes. Riley J; Glass J; Feldman EL; Polak M; Bordeau J; Federici T; Johe K; Boulis NM Neurosurgery; 2014 Jan; 74(1):77-87. PubMed ID: 24018694 [TBL] [Abstract][Full Text] [Related]
13. Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye. Li W; Kong F; Li X; Dai X; Liu X; Zheng Q; Wu R; Zhou X; Lü F; Chang B; Li Q; Hauswirth WW; Qu J; Pang JJ Mol Vis; 2009; 15():267-75. PubMed ID: 19190735 [TBL] [Abstract][Full Text] [Related]
15. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential. Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574 [TBL] [Abstract][Full Text] [Related]
16. Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates. Hackett NR; Redmond DE; Sondhi D; Giannaris EL; Vassallo E; Stratton J; Qiu J; Kaminsky SM; Lesser ML; Fisch GS; Rouselle SD; Crystal RG Hum Gene Ther; 2005 Dec; 16(12):1484-503. PubMed ID: 16390279 [TBL] [Abstract][Full Text] [Related]
17. Efficiencies of transgene expression in nociceptive neurons through different routes of delivery of adeno-associated viral vectors. Xu Y; Gu Y; Wu P; Li GW; Huang LY Hum Gene Ther; 2003 Jun; 14(9):897-906. PubMed ID: 12828860 [TBL] [Abstract][Full Text] [Related]
18. Neonatal intraperitoneal or intravenous injections of recombinant adeno-associated virus type 8 transduce dorsal root ganglia and lower motor neurons. Foust KD; Poirier A; Pacak CA; Mandel RJ; Flotte TR Hum Gene Ther; 2008 Jan; 19(1):61-70. PubMed ID: 18052722 [TBL] [Abstract][Full Text] [Related]
19. Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders. Bey K; Ciron C; Dubreil L; Deniaud J; Ledevin M; Cristini J; Blouin V; Aubourg P; Colle MA Gene Ther; 2017 May; 24(5):325-332. PubMed ID: 28425480 [TBL] [Abstract][Full Text] [Related]
20. Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B. George LA; Ragni MV; Rasko JEJ; Raffini LJ; Samelson-Jones BJ; Ozelo M; Hazbon M; Runowski AR; Wellman JA; Wachtel K; Chen Y; Anguela XM; Kuranda K; Mingozzi F; High KA Mol Ther; 2020 Sep; 28(9):2073-2082. PubMed ID: 32559433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]